Live Breaking News & Updates on Drug Discovery And Development

Stay updated with breaking news from Drug discovery and development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EVP CLO & General Counsel Patrick O'Neil Sells 20,825 Shares of Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc (NASDAQ:IONS), a leader in RNA-targeted drug discovery and development, has seen a recent insider transaction according to a SEC Filing. ....

Ionis-pharmaceuticals-inc , Gurufocus-value , Drug-discovery-and-development , Nsider-transaction , Atricko-39-neil , Urufocus , Fec-filing ,

Ionis Pharmaceuticals Inc EVP, Chief Scientific Officer C Bennett Sells 22,613 Shares

Ionis Pharmaceuticals Inc (NASDAQ:IONS), a leader in RNA-targeted drug discovery and development, has experienced a recent insider sell according to a SEC Filing. ....

Ionis-pharmaceuticals-inc , Drug-discovery-and-development , Nsider-transaction , Insider-activity , Nsider-transactions ,

Global Biomarkers Market: A Surge in Growth Driven by Health Trends

Global Biomarkers Market: A Surge in Growth Driven by Health Trends
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Brazil , India , Japan , France , China , Indonesia , United-states , Russia , Germany , South-korea , Australia

Addex Regains Nasdaq Listing Compliance

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 8, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced it had received written notification from The Nasdaq Stock Market LLC (Nasdaq) that it has regained compliance with the minimum bid price requirement of $1.00 per ADS under Nasdaq Listing Rule 5550(a)(2) and currently meets all other applicable cr ....

Switzerland , Geneva , Genè , United-states , Swiss , American , Mike-sinclair , Tim-dyer , Swiss-exchange , Nasdaq-stock-market , Nasdaq , Nasdaq-listing-rule